Panacea Biotec Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

6.13

6.13

6.13

6.13

6.13

Share application money

-

-

-

32.00

-

Preference share capital

4.98

4.15

3.45

2.90

10.54

Reserves & surplus

297.87

387.32

480.39

832.82

402.71

Loan funds

Secured loans

119.12

101.66

80.29

82.90

156.78

Unsecured loans

-

-

-

-

-

Total

428.10

499.25

570.25

956.73

576.16

Uses of funds

Fixed assets

Gross block

821.11

822.03

806.86

806.98

782.21

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

385.75

368.00

342.61

307.71

285.77

Net block

435.36

454.03

464.25

499.28

496.44

Capital work-in-progress

27.85

0.88

12.97

3.74

3.10

Investments

0.27

0.27

0.27

2.55

2.54

Net current assets

Current assets, loans & advances

260.43

306.66

314.08

632.93

939.96

Less : current liabilities & provisions

295.80

262.58

221.32

181.75

865.87

Total net current assets

-35.37

44.07

92.76

451.17

74.08

Miscellaneous expenses not written

-

-

-

-

-

Total

428.10

499.25

570.25

956.73

576.16

Notes:

Book value of unquoted investments

0.27

0.27

0.27

2.55

2.54

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

643.19

372.80

411.92

368.16

407.73

Number of equity sharesoutstanding (Lacs)

612.51

612.51

612.51

612.51

612.51